SELECT * FROM `stock_list` where symbol='539268' AND exchange = 'BOM' limit 0,1
SELECT * FROM `stock_list` where symbol='539268' AND exchange = 'BOM' limit 0,1
SELECT * FROM `stock_list` WHERE `symbol` = "539268" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1 Syngene International (BOM:539268) 6-1 Month Momentum %
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » 6-1 Month Momentum %

Syngene International (BOM:539268) 6-1 Month Momentum % : 3.14% (As of May. 01, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-01), Syngene International's 6-1 Month Momentum % is 3.14%.

The industry rank for Syngene International's 6-1 Month Momentum % or its related term are showing as below:

BOM:539268's 6-1 Month Momentum % is ranked worse than
50.53% of 1518 companies
in the Biotechnology industry
Industry Median: 4.14 vs BOM:539268: 3.14

Competitive Comparison of Syngene International's 6-1 Month Momentum %

For the Biotechnology subindustry, Syngene International's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Syngene International's 6-1 Month Momentum % falls into.



Syngene International  (BOM:539268) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (BOM:539268) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Syngene International 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Syngene International's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (BOM:539268) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines